A Novel Sphingosine Kinase Inhibitor Induces Autophagy in Tumor CellsS
The sphingolipids ceramide, sphingosine, and sphingosine 1-phosphate (S1P) regulate cell signaling, proliferation, apoptosis, and autophagy. Sphingosine kinase-1 and -2 (SK1 and SK2) phosphorylate sphingosine to form S1P, shifting the balanced activity of these lipids toward cell proliferation. We h...
Saved in:
Published in | The Journal of pharmacology and experimental therapeutics Vol. 333; no. 2; pp. 454 - 464 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
The American Society for Pharmacology and Experimental Therapeutics
01.05.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The sphingolipids ceramide, sphingosine, and sphingosine 1-phosphate (S1P) regulate
cell signaling, proliferation, apoptosis, and autophagy. Sphingosine kinase-1 and -2
(SK1 and SK2) phosphorylate sphingosine to form S1P, shifting the balanced activity
of these lipids toward cell proliferation. We have previously reported that
pharmacological inhibition of SK activity delays tumor growth in vivo. The present
studies demonstrate that the SK2-selective inhibitor
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide (ABC294640)
induces nonapoptotic cell death that is preceded by microtubule-associated protein
light chain 3 cleavage, morphological changes in lysosomes, formation of
autophagosomes, and increases in acidic vesicles in A-498 kidney carcinoma cells.
ABC294640 caused similar autophagic responses in PC-3 prostate and MDA-MB-231 breast
adenocarcinoma cells. Simultaneous exposure of A-498 cells to ABC294640 and
3-methyladenine, an inhibitor of autophagy, switched the mechanism of toxicity to
apoptosis, but decreased the potency of the SK2 inhibitor, indicating that autophagy
is a major mechanism for tumor cell killing by this compound. Induction of the
unfolded protein response by the proteasome inhibitor
N-
(benzyloxycarbonyl)leucinylleucinylleucinal
Z
-Leu-Leu-Leu-al (MG-132) or the heat shock protein 90 inhibitor
geldanamycin synergistically increased the cytotoxicity of ABC294640 in vitro. In
severe combined immunodeficient mice bearing A-498 xenografts, daily administration
of ABC294640 delayed tumor growth and elevated autophagy markers, but did not
increase terminal deoxynucleotidyltransferase-mediated dUTP nick end
labeling-positive cells in the tumors. These data suggest that ABC294640 promotes
tumor cell autophagy, which ultimately results in nonapoptotic cell death and a delay
of tumor growth in vivo. Consequently, ABC294640 may effectively complement
anticancer drugs that induce tumor cell apoptosis. |
---|---|
AbstractList | The sphingolipids ceramide, sphingosine, and sphingosine 1-phosphate (S1P) regulate
cell signaling, proliferation, apoptosis, and autophagy. Sphingosine kinase-1 and -2
(SK1 and SK2) phosphorylate sphingosine to form S1P, shifting the balanced activity
of these lipids toward cell proliferation. We have previously reported that
pharmacological inhibition of SK activity delays tumor growth in vivo. The present
studies demonstrate that the SK2-selective inhibitor
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide (ABC294640)
induces nonapoptotic cell death that is preceded by microtubule-associated protein
light chain 3 cleavage, morphological changes in lysosomes, formation of
autophagosomes, and increases in acidic vesicles in A-498 kidney carcinoma cells.
ABC294640 caused similar autophagic responses in PC-3 prostate and MDA-MB-231 breast
adenocarcinoma cells. Simultaneous exposure of A-498 cells to ABC294640 and
3-methyladenine, an inhibitor of autophagy, switched the mechanism of toxicity to
apoptosis, but decreased the potency of the SK2 inhibitor, indicating that autophagy
is a major mechanism for tumor cell killing by this compound. Induction of the
unfolded protein response by the proteasome inhibitor
N-
(benzyloxycarbonyl)leucinylleucinylleucinal
Z
-Leu-Leu-Leu-al (MG-132) or the heat shock protein 90 inhibitor
geldanamycin synergistically increased the cytotoxicity of ABC294640 in vitro. In
severe combined immunodeficient mice bearing A-498 xenografts, daily administration
of ABC294640 delayed tumor growth and elevated autophagy markers, but did not
increase terminal deoxynucleotidyltransferase-mediated dUTP nick end
labeling-positive cells in the tumors. These data suggest that ABC294640 promotes
tumor cell autophagy, which ultimately results in nonapoptotic cell death and a delay
of tumor growth in vivo. Consequently, ABC294640 may effectively complement
anticancer drugs that induce tumor cell apoptosis. |
Author | Beljanski, Vladimir Knaak, Christian Smith, Charles D. |
Author_xml | – sequence: 1 givenname: Vladimir surname: Beljanski fullname: Beljanski, Vladimir – sequence: 2 givenname: Christian surname: Knaak fullname: Knaak, Christian – sequence: 3 givenname: Charles D. surname: Smith fullname: Smith, Charles D. |
BookMark | eNqljM9rwjAYQD9E0Tp33jX_QGu-pD_Wy0BksiHsovcQ9VsbSZPQtIL__TzssvNO78GDt4Sp844AXpBniCJfXwMNGfI6w1JKWU0gwUJgypHLKSScC5HKoiwWsIzxyjnmeSnnsBAcqxqLKoHdhn35G1l2CK1xjY_GEdsbpyOxT9eakxl8_7DLeKbINuPgQ6ubOzOOHcfukbZkbTysYPatbaTnXz7B2-79uP1Iw3jq6HImN_TaqtCbTvd35bVRf4szrWr8TYnXStQlyn8PfgAr0FwV |
ContentType | Journal Article |
Copyright | Copyright © 2010 by The American Society for
Pharmacology and Experimental Therapeutics |
Copyright_xml | – notice: Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics |
DBID | 5PM |
DOI | 10.1124/jpet.109.163337 |
DatabaseName | PubMed Central (Full Participant titles) |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1521-0103 |
EndPage | 464 |
GrantInformation_xml | – fundername: National Institutes of Health grantid: CA138313-01 |
GroupedDBID | --- -~X .55 0R~ 18M 2WC 3O- 4.4 5GY 5PM 5RE AAYOK ABCQX ABIVO ABJNI ABOCM ABSQV ACGFO ACGFS ACNCT ADCOW ADIYS AENEX AETEA AFFNX AFHIN AFOSN ALMA_UNASSIGNED_HOLDINGS CS3 DIK DU5 E3Z EBS EJD F5P F9R GX1 H13 HZ~ INIJC KQ8 L7B LSO MJL O9- OK1 P2P R.V R0Z RHF RHI RPT TR2 W2D W8F WH7 WOQ X7M YBU YHG YQT |
ID | FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_28729613 |
ISSN | 0022-3565 |
IngestDate | Tue Sep 17 21:24:29 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-pubmedcentral_primary_oai_pubmedcentral_nih_gov_28729613 |
PMID | 20179157 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2872961 |
PublicationCentury | 2000 |
PublicationDate | 20100501 |
PublicationDateYYYYMMDD | 2010-05-01 |
PublicationDate_xml | – month: 5 year: 2010 text: 20100501 day: 1 |
PublicationDecade | 2010 |
PublicationTitle | The Journal of pharmacology and experimental therapeutics |
PublicationYear | 2010 |
Publisher | The American Society for Pharmacology and Experimental Therapeutics |
Publisher_xml | – name: The American Society for Pharmacology and Experimental Therapeutics |
SSID | ssj0014463 |
Score | 4.000463 |
Snippet | The sphingolipids ceramide, sphingosine, and sphingosine 1-phosphate (S1P) regulate
cell signaling, proliferation, apoptosis, and autophagy. Sphingosine... |
SourceID | pubmedcentral |
SourceType | Open Access Repository |
StartPage | 454 |
SubjectTerms | Cellular and Molecular |
Title | A Novel Sphingosine Kinase Inhibitor Induces Autophagy in Tumor CellsS |
URI | https://pubmed.ncbi.nlm.nih.gov/PMC2872961 |
Volume | 333 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT8IwFG-IXrwYP-N3ejBeBji2wdzFhOAHkUBImIYbaUeJ0zGIgon-kf5NvrfWrUMPymVZumzt-n7te31971dCTkFlucJzRMnFvXXHgjtmVngp8IZmFelGWICugXan1rx37vrVfqHwqUUtzWe8HHz8mleyjFShDOSKWbL_kGz6USiAe5AvXEHCcP2TjOtGZ_ImIqM3RT_SBEPYjVYYg2KCcf8YchitLwYezoFhV_U5cggwmejnz8fwqCGi6LWn26dZplhio04zYmvJ05Q7EEDL3cqc7SJ6Yt-HYT9EbBiOwzT-txUz9pxRGmjITB08avvfuCrr_gi5la75I_wsISbORZ52F1t8rbfYX2yxnmsgT5MoCzVFW-gAMW19Drclm4YCq6XNyI7kqFbK3ZGU6T_1huWg3oCFCvJrlcFItSUXjYai6TiBkYVzWEWyauf5u7vtBiDf8nA1vmq5XhVDTG_7acgRLr3tlL0e_kpRTUHl5wtVI0e1qmcxWlczf_wNsq4wQesShJukIOItcqZ6-71I9Z4t0jOqy2Gb3NRpglSqIZVKpNIUqVQhlaZIpWFME6RSidQdcnlz7TeapVxTB1PJmDJADvP8kzh8TLjMVYfZu2QlnsRij9CAO64ZVBkHyTlMCB7UhpzzC88UI3MoRvvEXbKSg6XfPCRrGdSPyMrsZS6OwRid8ZNEwl-qfZrf |
link.rule.ids | 230,315,786,790,891,27955,27956 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Novel+Sphingosine+Kinase+Inhibitor+Induces+Autophagy+in+Tumor+CellsS&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=Beljanski%2C+Vladimir&rft.au=Knaak%2C+Christian&rft.au=Smith%2C+Charles+D.&rft.date=2010-05-01&rft.pub=The+American+Society+for+Pharmacology+and+Experimental+Therapeutics&rft.issn=0022-3565&rft.eissn=1521-0103&rft.volume=333&rft.issue=2&rft.spage=454&rft.epage=464&rft_id=info:doi/10.1124%2Fjpet.109.163337&rft_id=info%3Apmid%2F20179157&rft.externalDBID=PMC2872961 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3565&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3565&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3565&client=summon |